AGP Executive Report
Last update: 9 hours agoPharmaceutical Industry: Georgian company GM PHARMA used the CPHI Milan exhibition to pursue international partnerships and showcase the country’s manufacturing capabilities. Surrogacy Safeguards: Georgia’s booming surrogacy market is outpacing protections, a DW report says: law covers clinics, parents and surrogates, but not agencies, leaving gaps over health information, pregnancy arrangements and payment guarantees. Protest-Related Health: A study reported this week found long-term health consequences among protesters exposed to chemical irritants in Georgia, renewing questions about the effects of crowd-control agents. Clinical Research: The first patients have been treated at Tbilisi’s Caucasus Medical Centre in the RELIVE trial of the Revivent heart device. Infectious-Disease Watch: Georgia’s health minister urged calm over a reported plague case in Russia, saying there was no reason for panic; international assessments also put the risk of spread very low.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
